FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE

This brand name is authorized in United States

Active ingredients

The drug FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE contains a combination of these active pharmaceutical ingredients (APIs):

1 Influenza, inactivated, surface antigen
UNII XW4JB03TI5 - INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Influenza, inactivated, surface antigen
2 Influenza, inactivated, surface antigen
UNII 9G0XU62HKP - INFLUENZA A VIRUS A/SOUTH AUSTRALIA/34/2019 IVR-197 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Influenza, inactivated, surface antigen
3 Influenza, inactivated, surface antigen
UNII B93BQX9789 - INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Influenza, inactivated, surface antigen
4 Influenza, inactivated, surface antigen
UNII VEH9U90EHX - INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Influenza, inactivated, surface antigen

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 49281-181, 49281-320, 49281-336

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈